REPLIGEN CORP (RGEN) Operating margin 2016–2025
REPLIGEN CORP (RGEN) operating margin by fiscal year — reported operating income divided by reported revenue.
7.5%FY2025 · since FY2016: 15.3% → 7.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 7.5% | +13.0 pp |
| FY2024 | -5.5% | -13.1 pp |
| FY2023 | 7.5% | -20.5 pp |
| FY2022 | 28.0% | +3.1 pp |
| FY2021 | 24.9% | +5.9 pp |
| FY2020 | 19.1% | +5.7 pp |
| FY2019 | 13.4% | -0.0 pp |
| FY2018 | 13.4% | +3.5 pp |
| FY2017 | 9.9% | -5.4 pp |
| FY2016 | 15.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGEN financial trends
RGEN RevenueRGEN Net incomeRGEN Net marginRGEN Gross profitRGEN Gross marginRGEN Operating incomeRGEN Operating cash flowRGEN Free cash flowRGEN Capital expendituresRGEN Return on equityRGEN Stock buybacksRGEN Dividends paidRGEN Total assetsRGEN Total liabilitiesRGEN Shareholders’ equityRGEN overview →